Camber Pharma Launches Generic Baraclude®
Piscataway, NJ, August 21, 2015– Camber Pharmaceuticals announces that it has launched Entecavir Tablets. The drug is the generic version of Baraclude®, which is used to treat chronic Hepatitis B.
Entecavir is available from Camber in .5mg 30 and 90 count bottles and 1mg 30 count bottles.
If you would like more information about this topic, please contact Megan Becker at 732.529.0436 or email at [email protected]
Recent articles
- 28 New Generics in 2022 and Anticipates Record Number of Approvals in 2023
- Camber Pharmaceuticals Launches Generic Cambia®
- Camber Pharmaceuticals Launches Generic Kuvan® Tablets and Powder for Oral Solution
- Camber Pharmaceuticals Launches Generic Vimpat® Injection
- Camber Pharmaceuticals Launches Generic Naprosyn®
- Camber Pharmaceuticals Launches Generic Lamictal XR®